Latest News

Skye Bioscience (SKYE) has scheduled a special call to present topline data from its Phase 2a clinical trial of Nimacimab, focusing on both monotherapy and combination treatment. Updates like these frequently shape investor sentiment around development-stage biotech stocks. See our latest analysis for Skye Bioscience. Skye Bioscience’s latest topline clinical update arrives after a period of muted share price action. Its stock closed at $1.90 and has shown minimal momentum over recent months...

If you are looking for the next move on Soho House & Co stock, you have probably noticed its eye-catching trajectory. This is not a slow and steady story, but one with dramatic swings and the kind of big numbers that spark conversation. Just over the past year, Soho House & Co’s shares have surged 69.1%. If you stretch that lens out to three years, we are talking 114.5% growth, which is well beyond what most lifestyle or hospitality names can boast. Even in recent months, the stock has kept...

If you have been watching Rush Enterprises, you may be asking yourself whether now is the moment to buy, hold, or move on. The stock price has slipped by 7.3% in the past week and it is down more than 14% over the last month. Year to date, shares have shed 8.8%. On a longer horizon, however, Rush Enterprises has quietly put together an impressive run, climbing 70.8% over three years and more than doubling investors’ money over five years with a 114.6% gain. That kind of return turns heads,...

On September 23, 2025, Appier Group announced the integration of Agentic AI technology across its entire product suite, launching eight specialized AI Agents designed to deliver autonomous marketing and real-time, data-driven insights for advertisers and marketers. This roll-out establishes a unified, adaptive marketing framework that enables brands to seamlessly connect and activate previously fragmented datasets through intelligent, self-learning automation. We'll explore how Appier's...

The Morning Bull - US Market Morning Update Tuesday, Oct, 7 2025 US stock futures are moving lower ahead of the open as persistent political uncertainty in both the US and Europe weighs on sentiment. With the US government shutdown showing no signs of resolution and French bond yields near multi-year highs because of fiscal and leadership gridlock, investors are focused on how these tensions could drive volatility and put pressure on areas of the market most sensitive to economic momentum and...

If you've been watching Ubtech Robotics lately, you're not alone, and for good reason. Investors are buzzing about its explosive stock performance, and anyone considering what to do next with the shares has a lot to consider. In just the last week, the stock delivered a 9.8% gain, while the past month saw a remarkable 45.0% climb. Year to date, Ubtech Robotics is up a stunning 192.8%. If you're comparing over the past year, the return is 31.0%, still an impressive showing in any market. These...

RBC Capital has reiterated its positive outlook for Brookfield Renewable, highlighting enhanced growth visibility and strong confidence in the company's long-term expansion plans following recent operational results. Despite reporting lower-than-expected Q2 2025 profits, Brookfield Renewable saw a 10% year-over-year rise in Funds From Operations, driven largely by its hydropower and distributed energy businesses. We'll examine how analyst confidence in Brookfield Renewable's operational...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 20x, you may...

Eagle Materials' (NYSE:EXP) stock up by 9.7% over the past three months. Given that the market rewards strong...

If you are considering what to do with Essex Property Trust stock right now, you are not alone. Many investors are weighing whether the recent dip is a sign of opportunity or cause for caution. After a three-year return of 32.5% and a five-year gain of 43.5%, Essex has clearly delivered for long-term investors. Lately, though, the story has been a little bumpier. The stock closed recently at $261.34, down 1.8% in the last week, 2.5% for the past month, and 6.5% year to date. Even over the...

On October 6, 2025, Senseonics Holdings announced preliminary unaudited revenue for the third quarter ended September 30, reporting approximately US$8.1 million, an increase of 91% over the same period in 2024, primarily attributed to roughly 160% new patient growth in the U.S. This upturn in both revenue and new patient adoption highlights more robust market traction, suggesting a potential acceleration in demand for the company’s continuous glucose monitoring systems. We’ll now explore how...

If you're standing at the crossroads of what to do with your Knife River shares or thinking of putting some capital to work, you're not alone. Knife River’s recent performance has grabbed the attention of both cautious investors and opportunists, sparking plenty of debate on whether the current price fairly reflects the company’s long-term prospects. Knife River's stock price has seen a difficult stretch lately. Down 3.9% in the last week, 11.6% in the last month, and a hefty 29.2%...

AC Immune (NasdaqGM:ACIU) just shared peer-reviewed data from its Phase 1b/2a trial of ACI-35.030, an active immunotherapy targeting Tau in early Alzheimer's, developed with Janssen. The findings highlight a rapid and sustained antibody response as well as a clean safety profile. See our latest analysis for AC Immune. With this encouraging clinical update, AC Immune is starting to turn heads, especially as the company’s latest innovation underscores its growing potential in Alzheimer’s...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

In September 2025, Bayer’s Consumer Health division announced it had selected Interpublic Group as its exclusive global creative, production, and media agency partner for iconic self-care brands including Aspirin and Claritin. This partnership signals Bayer’s commitment to integrated marketing powered by GenAI for both global consistency and tailored local consumer engagement. We'll review how IPG’s appointment as Bayer’s lead global partner could strengthen its client portfolio and...

Cheche Group Inc.'s ( NASDAQ:CCG ) price-to-sales (or "P/S") ratio of 0.2x may look like a pretty appealing investment...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

This week we saw the Netcompany Group A/S ( CPH:NETC ) share price climb by 18%. But that can't change the reality that...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...

Natura Cosméticos S.A. ( BVMF:NATU3 ), is not the largest company out there, but it saw significant share price...

Verizon Communications Inc. ( NYSE:VZ ) stock is about to trade ex-dividend in two days. The ex-dividend date is one...

When close to half the companies in Canada have price-to-earnings ratios (or "P/E's") above 17x, you may consider...

As the U.S. government shutdown unfolds, its immediate impact on economic data releases has left markets in a state of uncertainty, though the resilient consumer spending and robust AI investments continue to support growth. Amid these conditions, investors might find value in exploring penny stocks—an investment area that remains relevant despite its somewhat outdated terminology. These smaller or newer companies can offer unique opportunities for growth when backed by strong financials, and...

These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But one can do...